Cardiovascular and Endocrine Response to Muscular Training Program of Young Soccer Players Aged 14-18 Years
Sponsored by Hôpital Fribourgeois
About this trial
Last updated 2 years ago
Study ID
YoungSoccer_14-18
Status
Not yet recruiting
Type
Interventional
Phase
N/A
Placebo
No
Accepting
14 to 18 Years
Male
Trial Timing
Ended a year ago
What is this trial about?
This study focuses on understanding the cardiovascular and endocrine responses of young soccer players aged 14 to 18 years to a muscular training program. Adolescence is a critical period for physiological development, and investigating these responses can provide insights crucial for athletic performance and overall health. The benefits include promoting overall health, reducing injury risk, and enhancing scientific knowledge. However, intensive training programs may lead to overtraining and potential negative health outcomes if not carefully monitored. The study aims to assess whether additional neuromuscular development over 12 weeks can enhance players' physical fitness and hormonal changes. By examining these outcomes, the study seeks to inform evidence-based training protocols for optimizing adolescent athletes' health and performance in soccer. The study design involves a prospective single-center randomized cohort to investigate these responses comprehensively.
What are the participation requirements?
Inclusion Criteria
* Engaging in a football training program.
* No history of injuries in the last 6 months requiring surgical intervention.
* No intake of anabolic supplements.
* Age 14-18 years old.
* Normal BMI (18.5 - 24.9 kg/m²).
Parents and participants must consent to receive all pertinent information discovered during the study, such as potential cardiovascular diseases or hormonal disorders.
Participants must also consent to the sharing of certain private information with their parents or legal guardians. This includes information regarding cannabis use, as well as the consumption of anabolic steroids and other controlled substances. This additional consent ensures transparency and openness in sharing relevant health-related information with parents or legal guardians, particularly for participants under 18 years of age.
For participants under the age of 18, parental consent or consent from a legal guardian is mandatory in addition to the participant's consent. This ensures that minors have parental approval to take part in the study.
All participants, regardless of age, must provide their voluntary consent to participate in the study. For participants under the age of 18, consent from one of their parents or legal guardians is also required in addition to the participant's consent.
Exclusion Criteria
* Engaging in other supplemental individual exercise programs.
* Being a smoker (>1 cigarette/week).
* Using any medication at the time of testing.
* Having any disease.